Jump to main content
Jump to site search

Issue 9, 2011
Previous Article Next Article

Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs

Author affiliations

Abstract

Covering: up to the end of 2010

Natural products are made by nature through interaction with biosynthetic enzymes. Natural products also exert their effect as drugs by interaction with proteins. Does the recognition of the natural product by biosynthetic enzymes translate to recognition of the therapeutic target? Molecular modelling of flavonoid biosynthetic enzymes and kinases with a series of natural product kinase inhibitors led to the development of the concept of Protein Fold Topology (PFT). PFT describes cavity recognition points unrelated to protein fold similarity. The topology or spatial properties are preserved even though there is deformation of the protein elements that participate in the proteinligand interactions. We observe helices or β-strands as equivalent in providing the invariant topology for proteinligand interaction. In this Highlight, we explore the question: Will PFT aid drug discovery or is it the reason natural products have drug properties?

Graphical abstract: Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs

Back to tab navigation

Publication details

The article was received on 22 Mar 2011 and first published on 22 Jul 2011


Article type: Highlight
DOI: 10.1039/C1NP00026H
Nat. Prod. Rep., 2011,28, 1483-1492

  •   Request permissions

    Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs

    E. Kellenberger, A. Hofmann and R. J. Quinn, Nat. Prod. Rep., 2011, 28, 1483
    DOI: 10.1039/C1NP00026H

Search articles by author

Spotlight

Advertisements